Tridopa Tablet 150 mg+37.5 mg+200 mg is a high-strength combination therapy containing Levodopa, Carbidopa, and Entacapone, developed for the management of advanced Parkinson’s disease. This formulation provides a higher dose of Levodopa and Carbidopa for patients with severe motor fluctuations, offering enhanced control over symptoms such as tremors, rigidity, bradykinesia, and “off” periods.
-
Levodopa replenishes dopamine in the brain, improving motor function.
-
Carbidopa prevents peripheral breakdown of Levodopa, increasing its availability in the CNS and reducing nausea.
-
Entacapone inhibits COMT, prolonging Levodopa’s effect and stabilizing blood levels, reducing “wearing-off” phenomena.
Tridopa offers consistent symptom relief, improved mobility, and better quality of life for patients with Parkinsonism.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Indications
Tridopa Tablet 150 mg+37.5 mg+200 mg is indicated for:
-
Advanced idiopathic Parkinson’s disease with pronounced motor fluctuations
-
Patients experiencing frequent “off” episodes with lower-dose Levodopa therapy
-
Management of tremors, rigidity, bradykinesia, and postural instability
-
Adjunct therapy to optimize dopaminergic treatment and reduce complications
Mechanism of Action
The three components of Tridopa work synergistically:
-
Levodopa: Crosses the blood-brain barrier and converts to dopamine, compensating for deficient neurotransmitter levels in Parkinsonism.
-
Carbidopa: Inhibits peripheral decarboxylation of Levodopa, enhancing CNS delivery and minimizing gastrointestinal side effects.
-
Entacapone: COMT inhibitor that slows Levodopa metabolism, prolonging its action and stabilizing motor response.
This combination ensures sustained dopaminergic activity, reducing motor fluctuations and improving functional capacity.
Dosage and Administration
-
Recommended dose: 1 tablet (150 mg Levodopa + 37.5 mg Carbidopa + 200 mg Entacapone) at prescribed intervals, typically 3–4 times daily based on clinical response
-
Take with or immediately after meals to reduce nausea
-
Do not crush or chew the tablet
-
Gradual dose adjustments may be necessary in renal or hepatic impairment
-
Follow your physician’s guidance carefully to optimize symptom control
Benefits
-
Reduces “off” periods and motor fluctuations
-
Controls tremors, rigidity, and bradykinesia effectively
-
Improves mobility, coordination, and daily activity performance
-
Provides prolonged Levodopa effect with improved adherence
-
Enhances quality of life in patients with advanced Parkinson’s disease
Side Effects
Common side effects may include:
-
Nausea, vomiting, or gastrointestinal discomfort
-
Dizziness or orthostatic hypotension
-
Dyskinesia (involuntary movements)
-
Sleep disturbances or vivid dreams
Serious but rare side effects:
-
Severe psychiatric symptoms (hallucinations, confusion, psychosis)
-
Neuroleptic malignant-like syndrome (muscle rigidity, high fever)
-
Cardiovascular effects (arrhythmia, hypotension)
Immediate medical attention is required for severe psychiatric, neurological, or cardiovascular symptoms.
Precautions and Warnings
-
Use with caution in patients with cardiovascular disease, psychiatric disorders, or liver/kidney impairment
-
Monitor for impulse control disorders (gambling, hypersexuality)
-
Avoid abrupt discontinuation
-
Regular follow-up is essential to adjust dosing and monitor side effects
-
Pregnancy and breastfeeding: only use if clearly indicated and prescribed by a physician
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Drug Interactions
Tridopa may interact with:
-
MAO inhibitors (risk of hypertensive crisis)
-
Antipsychotics (may reduce Levodopa efficacy)
-
Dopamine agonists or other Parkinson’s medications (dose adjustments may be required)
-
Drugs affecting hepatic or renal metabolism
Always inform your healthcare provider about all medications and supplements prior to starting therapy.
Storage
-
Store below 25°C in a dry, cool place
-
Protect from light and moisture
-
Keep out of reach of children
-
Do not use after the expiration date.